Screening for deficits using the G8 and VES-13 in older patients with Myelodysplastic syndromes

Angela Molga; Michelle Wall; Li Yan A. Wee; Rakchha Chhetri; Deepak Singhal; Nimit Singhal; Luen Bik To; Sepehr Shakib; Timothy To; Devendra Hiwase

doi:10.1016/j.jgo.2019.04.012

Screening for deficits using the G8 and VES-13 in older patients with Myelodysplastic syndromes

Angela Molga, Michelle Wall, Li Yan A. Wee, Rakchha Chhetri, Deepak Singhal, Nimit Singhal, Luen Bik To, Sepehr Shakib, Timothy To, Devendra Hiwase

Research output: Contribution to journal › Letter › peer-review

5 Citations (Scopus)

Abstract

The incidence of myelodysplastic syndromes (MDS) increases with age. Older patients with MDS have a poor prognosis, further influenced by individual factors such as comorbidity, functional status and cognitive status [1]. Currently, patient's performance status is assessed using criteria outlined by Eastern Cooperative Oncology Group (ECOG). An ECOG score of 0–2 is considered ‘fit’, while a score of 3 is considered ‘vulnerable’. Routine hematology assessment does not routinely identify all geriatric related health issues and hence a comprehensive geriatric assessment (CGA) is recommended to detect vulnerability to adverse outcomes in older patients with cancer [2].

Original language	English
Pages (from-to)	128-130
Number of pages	3
Journal	Journal of Geriatric Oncology
Volume	11
Issue number	1
DOIs	https://doi.org/10.1016/j.jgo.2019.04.012
Publication status	Published - Jan 2020
Externally published	Yes

Keywords

Myelodysplastic syndromes
Screening
G8
VES-13

Access to Document

10.1016/j.jgo.2019.04.012Licence: In Copyright

Cite this

@article{68d8d4a182f641c6a233cfd31d7108be,

title = "Screening for deficits using the G8 and VES-13 in older patients with Myelodysplastic syndromes",

abstract = "The incidence of myelodysplastic syndromes (MDS) increases with age. Older patients with MDS have a poor prognosis, further influenced by individual factors such as comorbidity, functional status and cognitive status [1]. Currently, patient's performance status is assessed using criteria outlined by Eastern Cooperative Oncology Group (ECOG). An ECOG score of 0–2 is considered {\textquoteleft}fit{\textquoteright}, while a score of 3 is considered {\textquoteleft}vulnerable{\textquoteright}. Routine hematology assessment does not routinely identify all geriatric related health issues and hence a comprehensive geriatric assessment (CGA) is recommended to detect vulnerability to adverse outcomes in older patients with cancer [2].",

keywords = "Myelodysplastic syndromes, Screening, G8, VES-13",

author = "Angela Molga and Michelle Wall and Wee, {Li Yan A.} and Rakchha Chhetri and Deepak Singhal and Nimit Singhal and To, {Luen Bik} and Sepehr Shakib and Timothy To and Devendra Hiwase",

year = "2020",

month = jan,

doi = "10.1016/j.jgo.2019.04.012",

language = "English",

volume = "11",

pages = "128--130",

journal = "Journal of Geriatric Oncology",

issn = "1879-4068",

publisher = "Elsevier Ltd.",

number = "1",

}

TY - JOUR

T1 - Screening for deficits using the G8 and VES-13 in older patients with Myelodysplastic syndromes

AU - Molga, Angela

AU - Wall, Michelle

AU - Wee, Li Yan A.

AU - Chhetri, Rakchha

AU - Singhal, Deepak

AU - Singhal, Nimit

AU - To, Luen Bik

AU - Shakib, Sepehr

AU - To, Timothy

AU - Hiwase, Devendra

PY - 2020/1

Y1 - 2020/1

N2 - The incidence of myelodysplastic syndromes (MDS) increases with age. Older patients with MDS have a poor prognosis, further influenced by individual factors such as comorbidity, functional status and cognitive status [1]. Currently, patient's performance status is assessed using criteria outlined by Eastern Cooperative Oncology Group (ECOG). An ECOG score of 0–2 is considered ‘fit’, while a score of 3 is considered ‘vulnerable’. Routine hematology assessment does not routinely identify all geriatric related health issues and hence a comprehensive geriatric assessment (CGA) is recommended to detect vulnerability to adverse outcomes in older patients with cancer [2].

AB - The incidence of myelodysplastic syndromes (MDS) increases with age. Older patients with MDS have a poor prognosis, further influenced by individual factors such as comorbidity, functional status and cognitive status [1]. Currently, patient's performance status is assessed using criteria outlined by Eastern Cooperative Oncology Group (ECOG). An ECOG score of 0–2 is considered ‘fit’, while a score of 3 is considered ‘vulnerable’. Routine hematology assessment does not routinely identify all geriatric related health issues and hence a comprehensive geriatric assessment (CGA) is recommended to detect vulnerability to adverse outcomes in older patients with cancer [2].

KW - Myelodysplastic syndromes

KW - Screening

KW - G8

KW - VES-13

UR - http://www.scopus.com/inward/record.url?scp=85077126435&partnerID=8YFLogxK

U2 - 10.1016/j.jgo.2019.04.012

DO - 10.1016/j.jgo.2019.04.012

M3 - Letter

C2 - 31053426

AN - SCOPUS:85077126435

SN - 1879-4068

VL - 11

SP - 128

EP - 130

JO - Journal of Geriatric Oncology

JF - Journal of Geriatric Oncology

IS - 1

ER -

Screening for deficits using the G8 and VES-13 in older patients with Myelodysplastic syndromes

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this